These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

541 related items for PubMed ID: 8692619

  • 1. A controlled trial of dexamethasone to prevent bronchopulmonary dysplasia in surfactant-treated infants.
    Rastogi A, Akintorin SM, Bez ML, Morales P, Pildes RS.
    Pediatrics; 1996 Aug; 98(2 Pt 1):204-10. PubMed ID: 8692619
    [Abstract] [Full Text] [Related]

  • 2. Randomized, double-blinded trial of low-dose dexamethasone: II. Functional residual capacity and pulmonary outcome in very low birth weight infants at risk for bronchopulmonary dysplasia.
    McEvoy C, Bowling S, Williamson K, McGaw P, Durand M.
    Pediatr Pulmonol; 2004 Jul; 38(1):55-63. PubMed ID: 15170874
    [Abstract] [Full Text] [Related]

  • 3. A multicenter trial of two dexamethasone regimens in ventilator-dependent premature infants.
    Papile LA, Tyson JE, Stoll BJ, Wright LL, Donovan EF, Bauer CR, Krause-Steinrauf H, Verter J, Korones SB, Lemons JA, Fanaroff AA, Stevenson DK.
    N Engl J Med; 1998 Apr 16; 338(16):1112-8. PubMed ID: 9545359
    [Abstract] [Full Text] [Related]

  • 4. A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group.
    Long W, Corbet A, Cotton R, Courtney S, McGuiness G, Walter D, Watts J, Smyth J, Bard H, Chernick V.
    N Engl J Med; 1991 Dec 12; 325(24):1696-703. PubMed ID: 1944470
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Respiratory burst activity in bronchopulmonary dysplasia and changes with dexamethasone.
    Ballabh P, Simm M, Kumari J, Califano C, Aghai Z, Laborada G, Sison C, Cunningham-Rundles S.
    Pediatr Pulmonol; 2003 May 12; 35(5):392-9. PubMed ID: 12687597
    [Abstract] [Full Text] [Related]

  • 12. A pilot randomized, controlled trial of later treatment with a peptide-containing, synthetic surfactant for the prevention of bronchopulmonary dysplasia.
    Laughon M, Bose C, Moya F, Aschner J, Donn SM, Morabito C, Cummings JJ, Segal R, Guardia C, Liu G, Surfaxin Study Group.
    Pediatrics; 2009 Jan 12; 123(1):89-96. PubMed ID: 19117865
    [Abstract] [Full Text] [Related]

  • 13. Azithromycin in the extremely low birth weight infant for the prevention of bronchopulmonary dysplasia: a pilot study.
    Ballard HO, Anstead MI, Shook LA.
    Respir Res; 2007 Jun 05; 8(1):41. PubMed ID: 17550598
    [Abstract] [Full Text] [Related]

  • 14. A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome.
    Sinha SK, Lacaze-Masmonteil T, Valls i Soler A, Wiswell TE, Gadzinowski J, Hajdu J, Bernstein G, Sanchez-Luna M, Segal R, Schaber CJ, Massaro J, d'Agostino R, Surfaxin Therapy Against Respiratory Distress Syndrome Collaborative Group.
    Pediatrics; 2005 Apr 05; 115(4):1030-8. PubMed ID: 15805381
    [Abstract] [Full Text] [Related]

  • 15. Surfactant treatment in premature infants with Respiratory Distress Syndrome in Curaçao.
    Verhagen AA, Keli SO, van der Meulen GN, Wiersma H, Arias M, Angelista IR, Muskiet FD.
    West Indian Med J; 2001 Jun 05; 50(2):117-22. PubMed ID: 11677907
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Nasal CPAP or intubation at birth for very preterm infants.
    Morley CJ, Davis PG, Doyle LW, Brion LP, Hascoet JM, Carlin JB, COIN Trial Investigators.
    N Engl J Med; 2008 Feb 14; 358(7):700-8. PubMed ID: 18272893
    [Abstract] [Full Text] [Related]

  • 19. Surfactant replacement therapy with a single postventilatory dose of a reconstituted bovine surfactant in preterm neonates with respiratory distress syndrome: final analysis of a multicenter, double-blind, randomized trial and comparison with similar trials. The Surfactant-TA Study Group.
    Fujiwara T, Konishi M, Chida S, Okuyama K, Ogawa Y, Takeuchi Y, Nishida H, Kito H, Fujimura M, Nakamura H.
    Pediatrics; 1990 Nov 14; 86(5):753-64. PubMed ID: 2235230
    [Abstract] [Full Text] [Related]

  • 20. Nebulized pentoxifylline for prevention of bronchopulmonary dysplasia in very low birth weight infants: a pilot clinical study.
    Lauterbach R, Szymura-Oleksiak J, Pawlik D, Warchoł J, Lisowska-Miszczyk I, Rytlewski K.
    J Matern Fetal Neonatal Med; 2006 Jul 14; 19(7):433-8. PubMed ID: 16923699
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.